Discontinued — last reported Q4 '25
Newmont Business Sale Proceeds increased by 313.6% to $91.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 94.6%, from $1.68B to $91.00M. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows an upward trend with a 140.5% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $3.00M | $80.00M | $4.00M | $4.00M | $4.00M | $4.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $180.00M | $150.00M | $230.00M | $1.68B | $991.00M | $114.00M | $22.00M | $91.00M |
| QoQ Change | — | — | >999% | -95.0% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | — | — | -16.7% | +53.3% | +632.2% | -41.2% | -88.5% | -80.7% | +313.6% |
| YoY Change | — | — | — | — | — | +33.3% | -95.0% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | — | +450.6% | -24.0% | -90.4% | -94.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.